| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |